Literature DB >> 15661885

The role of p53 and Fas in a model of acute murine graft-versus-host disease.

Shinichiro Yada1, Noriaki Takamura, Kyoko Inagaki-Ohara, Melissa K O'leary, Christoph Wasem, Thomas Brunner, Douglas R Green, Tesu Lin, Michael J Pinkoski.   

Abstract

Graft-vs-host disease (GVHD) is a devastating, frequently fatal, pathological condition associated with lesions in specific target organs, including the intestine, liver, lung, and skin, as well as pancytopenia and alopecia. Bone marrow (BM) atrophy is observed in acutely diseased animals, but the underlying mechanisms of hemopoietic stem cell depletion remained to be established. We used an experimental mouse model of acute GVHD in which parental cells were injected into F(1) hosts preconditioned by sublethal irradiation. The resulting graft-vs-host response was kinetically consistent, resulting in lethality within 3 wk. We observed disease pathology in the liver and small intestine, and consistent with previous observations, we found BM atrophy to be a factor in the onset of acute disease. The product of the protooncogene, p53, is known to be a key player in many physiological examples of apoptosis. We investigated the role of p53 in the apoptosis of BM cells (BMC) during the development of acute disease and found that at least one copy of the p53 gene is necessary for depletion of BM and subsequent lethality in host animals. BM depletion was preceded by induction of the death receptor, Fas, on the surface of host stem cells, and induction of Fas was coincidental with the sensitization of BMC to Fas-mediated apoptosis. Our data indicate that BM depletion in acute GVHD is mediated by p53-dependent up-regulation of Fas on BMC, which leads to Fas-dependent depletion and subsequent disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661885     DOI: 10.4049/jimmunol.174.3.1291

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.

Authors:  Stephen P Persaud; Julie K Ritchey; Sena Kim; Sora Lim; Peter G Ruminski; Matthew L Cooper; Michael P Rettig; Jaebok Choi; John F DiPersio
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

Review 2.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Authors:  H Joachim Deeg; Emily Spaulding; Howard M Shulman
Journal:  Leuk Lymphoma       Date:  2009-10

3.  Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.

Authors:  Steven Bair; Emily Spaulding; Jaakko Parkkinen; Howard M Shulman; Vladimir Lesnikov; Mary Beauchamp; François Canonne-Hergaux; Kris V Kowdley; H Joachim Deeg
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

Review 4.  Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Wei Du; Xuefang Cao
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

5.  Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.

Authors:  Justine E Roderick; Gabriela Gonzalez-Perez; Christina Arieta Kuksin; Anushka Dongre; Emily R Roberts; Janani Srinivasan; Chester Andrzejewski; Abdul H Fauq; Todd E Golde; Lucio Miele; Lisa M Minter
Journal:  J Exp Med       Date:  2013-06-03       Impact factor: 14.307

6.  Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.

Authors:  Sadaf Atarod; Jean Norden; Louis A Bibby; Anne Janin; Philippe Ratajczak; Clare Lendrem; Kim F Pearce; Xiao-Nong Wang; Steven O'Reilly; Jacob M Van Laar; Matthew Collin; Anne M Dickinson; Rachel E Crossland
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.